BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Europabio - ECPv6.15.16.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Europabio
X-ORIGINAL-URL:https://www.europabio.org
X-WR-CALDESC:Events for Europabio
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Brussels
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20220327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20221030T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20231029T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20241027T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20230601T100000
DTEND;TZID=Europe/Brussels:20230601T190000
DTSTAMP:20260702T180910
CREATED:20230321T205822Z
LAST-MODIFIED:20230321T210149Z
UID:6071-1685613600-1685646000@www.europabio.org
SUMMARY:KNOWLEDGE FOR GROWTH 2023
DESCRIPTION:Knowledge for Growth is Europe’s finest life sciences conference.For the first time the event will take place in Antwerp.\n\n\n\nThe conference features an exciting programme providing vital insight into the global life sciences’ landscape\, one-to-one partnering\, a trade fair and more! \n\n\n\nLEARN. CONNECT. DISCOVER.\n\n\n\nThe cream of the Belgian life sciences community attends flanders.bio’s annual Knowledge for Growth business conference\, attracting decision makers from biotech\, pharma and medtech\, agricultural and chemical industry as well as investors\, universities\, top-notch research institutes\, policymakers and competence providers. \n\n\n\n\nMore information
URL:https://www.europabio.org/event/knowledge-for-growth-2023/
LOCATION:Flanders Meeting & Convention Center Antwerp\, Koningin Astridplein 26\, Antwerp\, 2018\, Belgium
CATEGORIES:External,Industrial Biotech
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2023/03/Event-Page-5.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20230605T173000
DTEND;TZID=Europe/Brussels:20230605T183000
DTSTAMP:20260702T180910
CREATED:20230523T115247Z
LAST-MODIFIED:20230524T142835Z
UID:6282-1685986200-1685989800@www.europabio.org
SUMMARY:EuropaBio: BIO 2023
DESCRIPTION:Round table –Biomanufacturing for health: advancing healthcare and global preparedness \n\n\n\n\n\nEuropaBio is pleased to host a round table discussion at the upcoming BIO International Convention in Boston and invites all delegates to join us to discuss on biomanufacturing for health: advancing healthcare and global prepareness.  \n\n\n\nBiomanufacturing within healthcare represents an advance in therapeutic capabilities\, as ground-breaking research translates into increased diseases that can be targeted\, either for the first time or with greater efficacy\, with increasingly complex interventions becoming possible. It also brings resilience and increased environmental sustainability to strained supply chains as the world strives to modernise production systems. \n\n\n\nThe transition has significant implications for global healthcare\, competitiveness\, sustainability and resilience\, with capacity building important in all regions. \n\n\n\nThis is not just reflected in advancing healthcare for citizens but also for the world’s ability to respond to healthcare crises.  Covid demonstrated that  biomanufacturing capacity globally was called into action from multiple applications and countries for the complex manufacturing process behind vaccines. \n\n\n\nThis biomanufacturing capacity does not exist within a vacuum\, ready to be called to action when needed. It requires drug developers large and small\, public and private\, specialised manufacturers\, plus skills base\, supply chain and logistics frameworks resulting from significant investment over many years. \n\n\n\nImportantly\, a sustainable biomanufacturing framework is financed and delivered primarily through industry\, meaning that is must be integral to company strategy. This is not a guarantee\, as the global healthcare industry reacts to legislative changes and government strategies\, with major investment decisions having long term implications for the capacity and skills base within countries and regions. \n\n\n\nWhat does the world need to get right to ensure that biomanufacturing capacity grows\, to serve patients with advancing therapies and be there for coordinated emergency responses? \n\n\n\nParticipants within the round table reflect global biomanufacturing stakeholders and will discuss: \n\n\n\n\nNational policies\, incentives and strategy\n\n\n\nRegulatory and standards and alignment\n\n\n\nInternational cooperation and development\n\n\n\n\nThe output from this roundtable will be a call to global action for biomanufacturing published through EuropaBio and BIO\, with all delegates invited to contribute through the round table and follow up. \n\n\n\nAgenda \n\n\n\n10:30Welcome and introductionEuropaBio and BIO10:40Setting the scene for global biomanufacturing and the planned outcome from the round tableClaire10:45(draft) Discussion points for participants: – What does your country need to achieve for resilience through national or accessible biomanufacturing capacity?– How are regulatory frameworks adapting to an increasingly biological pipeline of medicines?– What does international cooperation need to achieve to ensure that manufacturing is actually possible during pandemic responses?– Name a priority for you to reach biomanufacturing goals in the coming years.All participants: Lead interventions on specific topics11:30Closing remarksEuropaBio and BIO\n\n\n\n\n\n\n\n \n\n\n\n\nMore information here
URL:https://www.europabio.org/event/europabio-bio-2023/
LOCATION:Boston Convention & Exhibition Center\, Boston\, Massachusetts\, United States
CATEGORIES:EuropaBio
ATTACH;FMTTYPE=image/jpeg:https://www.europabio.org/wp-content/uploads/2023/05/Event-Banners-Website.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20230615T080000
DTEND;TZID=Europe/Brussels:20230617T180000
DTSTAMP:20260702T180910
CREATED:20230516T094713Z
LAST-MODIFIED:20230516T104047Z
UID:6258-1686816000-1687024800@www.europabio.org
SUMMARY:3rd Hellenic Biocluster Forum
DESCRIPTION:The Hellenic BioCluster is organizing its 3rd Forum on the subject of “Supporting disruptive innovation to maximize the economic and social impact of the bio-industry sector”\, scheduled to be held between 15 – 17 June 2023 at Megaron Athens International Conference Centre\, Athens\, Greece. \n\n\n\nThe 3rd HBio Forum features a 3-day\, cutting-edge programme with inspiring speakers from across the globe\, all experts in disruptive innovation\, with the aim to connect the global biotech innovation community under the sunny Athens skies. During the Forum B2B meeting opportunities will be provided between attendees and sponsors/exhibitors. \n\n\n\nThe 3rd HBio Forum will also include targeted panels of industry experts\, mentors and life sciences professionals to discuss hot topics related to investment such as raising capital and achieving success\, followed by a Pitching Competition. \n\n\n\n\nMore Details
URL:https://www.europabio.org/event/3rd-hellenic-biocluster-forum/
LOCATION:Megaron Athens International Conference Centre\, Athens\, Greece
CATEGORIES:External
ATTACH;FMTTYPE=image/jpeg:https://www.europabio.org/wp-content/uploads/2023/05/External-Events-Banners-2.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20230616T083000
DTEND;TZID=Europe/Brussels:20230616T100000
DTSTAMP:20260702T180910
CREATED:20230524T085454Z
LAST-MODIFIED:20230524T142847Z
UID:6326-1686904200-1686909600@www.europabio.org
SUMMARY:GREEK BIOPHARMA INNOVATION: Your changing world with the new EU Pharma Legislation
DESCRIPTION:Chairperson: Claire Skentelbery\, Director General EuropaBio \n\n\n\nParticipants: \n\n\n\nKostas Papagiannis Country President & Managing Director Novartis Greece \n\n\n\nHardy Rideout Anacalypsis Therapeutics \n\n\n\nGeorge Drakakis CEO PurposefulEU pharma legislation is going to change your business. What you make\, where and how you sell it\, and whether your business model is even viable.The European Commission published new legislative proposals in April that will redefine the business model of biotechnology in Europe. In trying to bring medicines to more patients\, the legislation proposals reduce data protection\, limit exclusivity for orphan medicines and brings heavy pressure to launch in all 27 Member States within two years of EMA approval.Changing the rule book that has helped build Europe’s small company ecosystem over the last 20 years is going to have consequences for start-ups\, those seeking scale up investment\, clinical trials and companies going to market\, often for the first time.This session/panel\, chaired by EuropaBio\, presents the key impacts points for biotechnology innovation within Greece\, with contributions from small and large companies and policy makers – bring your voice to the discussion for the future of your own science. \n\n\n\n\nMore information
URL:https://www.europabio.org/event/greek-biopharma-innovation-your-changing-world-with-the-new-eu-pharma-legislation/
LOCATION:Megaron Athens International Conference Centre\, Athens\, Greece
CATEGORIES:External
ATTACH;FMTTYPE=image/jpeg:https://www.europabio.org/wp-content/uploads/2023/05/External-Events-Banners-600-×-200px-2.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20230622T140000
DTEND;TZID=Europe/Brussels:20230622T160000
DTSTAMP:20260702T180910
CREATED:20230414T130232Z
LAST-MODIFIED:20230621T083523Z
UID:6128-1687442400-1687449600@www.europabio.org
SUMMARY:EuropaBio National Associations Council Summit 2023 (Spanish Presidency): A global Europe - the role of transformative legislation
DESCRIPTION:Spain will hold the Presidency of the Council of the European Union for the fifth time in the second half of 2023\, between July 1 and December 31. In a pivotal time for the Biotechnology industry\, Spain will lead the dialogue on the European Commission’s proposal on new genomic techniques (NGT) and the revision of the Pharmaceutical Strategy for Europe – critical policies for European patients\, Europe’s food security and the green transition. \n\n\n\nEuropaBio – the European Association for Bioindustries and AseBio\, the Spanish Association of Biotechnology Companies\, are proud hosts of EuropaBio’s National Associations Council (NAC) annual Presidency Summit. Invited speakers from industry\, policymakers\, and national biotechnology associations will explore the latest policy developments and offer their insights into the upcoming work and ambitions of the Spanish Council Presidency. \n\n\n\nThe Summit will be public and held online on June 22. The event will be followed by a Summer reception on June 27 in Brussels to present our participants’ key messaging and recommendations. \n\n\n\nIf you wish to attend our session or have any questions\, insights or suggestions\, please do not hesitate to reach José Peres at j.peres@europabio.org.  \n\n\n\nAgenda \n\n\n\nOpening remarks \n\n\n\n\nTineke Van hooland\, Deputy Secretary General at bio.be/essenscia\, Chair of the National Associations Council (NAC) at EuropaBio\n\n\n\n\nPanel I: Innovation for European Patients: the European pharmaceutical legislation \n\n\n\n\nMEP Dolors Montserrat (EPP)\n\n\n\nAna Polanco\, AseBio Chair of the Board\, Head of European Government and Public Affairs\, and Market Access and Pricing at Merck\n\n\n\nDr Jessica Martinsson\, Director General at SwedenBio\n\n\n\nMaria Pascual\, Chief Regulatory Officer at Minoryx Therapeutics\n\n\n\nModeration: Vlad Olteanu\, Healthcare Public Affairs Director at EuropaBio\n\n\n\n\nPanel II: Resilience\, sustainability and competitiveness for Europe’s food chain: new genomic techniques \n\n\n\n\nIlaria Ciabatti\, Team Leader Biotechnology Unit\, European Commission DG Santé\n\n\n\nIon Arocena Vélez\, Director General at AseBio – the Spanish Association of Biotechnology Companies\n\n\n\nElke Duwenig\, Senior Expert Global Regulatory / Public & Government Affairs Biotechnology\, Nutrition & Health at BASF\n\n\n\nOana Dima\, Executive Manager of the EU-SAGE network\, Science Policy Manager at VIB-Ghent University Center for Plant Systems Biology\n\n\n\nTomasz Zimny\,  Assistant Professor at the Institute of Law Studies\, Polish Academy of Sciences\, Warszawa\, Poland\n\n\n\nAna Judith Martín de la Fuente\, Head of Area/Secretary of the Interministerial Council of GMOs at the Spanish Ministry of Agriculture\, Food and Fisheries\n\n\n\nModeration: Anne-Gaelle Collot\, Industrial Biotechnology Director at EuropaBio\n\n\n\n\nClosing remarks \n\n\n\n\nClaire Skentelbery\, Director General at EuropaBio\n\n\n\n\n \n\n\n\n\nRegister here
URL:https://www.europabio.org/event/europabio-national-associations-council-summit-2023-spanish-presidency-a-global-europe-the-role-of-transformative-legislation/
ATTACH;FMTTYPE=image/jpeg:https://www.europabio.org/wp-content/uploads/2023/04/NAC-SUMMIT-BANNER-V2A.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20230627T140000
DTEND;TZID=Europe/Brussels:20230627T160000
DTSTAMP:20260702T180910
CREATED:20230516T093527Z
LAST-MODIFIED:20230517T184028Z
UID:6244-1687874400-1687881600@www.europabio.org
SUMMARY:Reflection seminar and closing party around the EU presidency
DESCRIPTION:On June 27\, a Life Science conference is arranged for EU parliamentarians during Sweden’s EU presidency. \n\n\n\nDirectly after the official conference\, The Royal Academy of Engineering Sciences (IVA) and SwedenBIO invites the public to a seminar with the spotlight on how the suggested EU legislations may affect the life science industry. With examples from the Swedish life science arena\, we show the importance of intellectual property and data protection in the journey from academic research to products and therapies for patients. \n\n\n\nAfterward\, a networking reception is organized by the united life science industry organisations. With drinks\, snacks\, and key speakers\, we ensure that the end of the presidency marks the start of an even stronger united life science industry in Sweden and beyond. \n\n\n\n\nMore details
URL:https://www.europabio.org/event/reflection-seminar-and-closing-party-around-the-eu-presidency/
LOCATION:IVA Conference Center\, Grev Turegatan 15\, Stockholm\, Sweden
CATEGORIES:External
ATTACH;FMTTYPE=image/jpeg:https://www.europabio.org/wp-content/uploads/2023/05/External-Events-Banners.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20230627T180000
DTEND;TZID=Europe/Brussels:20230627T200000
DTSTAMP:20260702T180910
CREATED:20230524T142640Z
LAST-MODIFIED:20230616T172415Z
UID:6330-1687888800-1687896000@www.europabio.org
SUMMARY:NAC Spanish Presidency Summer Reception
DESCRIPTION:EuropaBio\, and AseBio\, the Spanish Association of Biotechnology Companies\, with the support of Merck\, will host a summer reception to mark the beginning of the Spanish Council Presidency of the European Union and present the outcomes of their National Association Council Presidency Summit.  \n\n\n\nThe event will take place on June 27th in Brussels at Comet Meetings – Louise\, from 18-20h. If you wish for more details\, please get in touch with José Peres at j.peres@europabio.org 
URL:https://www.europabio.org/event/nac-spanish-presidency-summer-reception/
CATEGORIES:EuropaBio
ATTACH;FMTTYPE=image/jpeg:https://www.europabio.org/wp-content/uploads/2023/05/NAC-Summer-Reception-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20230630T124500
DTEND;TZID=Europe/Brussels:20230630T124500
DTSTAMP:20260702T180910
CREATED:20230321T210403Z
LAST-MODIFIED:20230321T210405Z
UID:6074-1688129100-1688129100@www.europabio.org
SUMMARY:DUTCH BIOTECH EVENT 2023
DESCRIPTION:Join us to celebrate the power of biotech at the Dutch Biotech Event 2023! \n\n\n\nAbout HollandBIO’s Dutch Biotech Event \n\n\n\nThe program features inspiring talks by keynote speakers on biotech and entrepreneurship\, followed by workshops and break-out sessions that contribute to your personal development and that of your company. In addition\, there will be plenty of opportunities for networking during the break\, drinks and vegetarian BBQ. \n\n\n\nWho can join Dutch Biotech Event? \n\n\n\nThe Dutch Biotech Event welcomes HollandBIO members (registration free of charge) and employees of other biotech R&D companies (registration fee €295\,- p.p.)\, with a maximum of 2 delegates per organization. \n\n\n\nWe invite non-member startups to consider a HollandBIO membership (€562\,-/year)\, which besides access to the network & events\, offers many more advantages. \n\n\n\n\nMore information
URL:https://www.europabio.org/event/dutch-biotech-event-2023/
LOCATION:Inn Style\, Herenweg 55\, Maarssen\, 3602 AN\, Netherlands
CATEGORIES:External,Industrial Biotech
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2023/03/Event-Page-2.png
END:VEVENT
END:VCALENDAR